{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:55:03Z","timestamp":1790016903708,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1378\/chest.11-2307","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T02:39:00Z","timestamp":1328582340000},"page":"e669S-e690S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"special_numbering":"S","title":["Antithrombotic Therapy in Peripheral Artery Disease"],"prefix":"10.1016","volume":"141","author":[{"given":"Pablo","family":"Alonso-Coello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McGorrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Criqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Olav","family":"Vandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten G.","family":"Lansberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9754","key":"10.1378\/chest.11-2307_bib1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1378\/chest.11-2307_bib2","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-2307_bib3","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1378\/chest.11-2288","article-title":"Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"2 suppl","key":"10.1378\/chest.11-2307_bib4","first-page":"e637S","article-title":"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Vandvik","year":"2011","journal-title":"Chest"},{"issue":"7070","key":"10.1378\/chest.11-2307_bib5","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.313.7070.1440","article-title":"Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study","volume":"313","author":"Leng","year":"1996","journal-title":"BMJ"},{"issue":"3","key":"10.1378\/chest.11-2307_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.ATV.19.3.538","article-title":"Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study","volume":"19","author":"Newman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1378\/chest.11-2307_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","article-title":"Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study","volume":"109","author":"Resnick","year":"2004","journal-title":"Circulation"},{"issue":"8880","key":"10.1378\/chest.11-2307_bib8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0140-6736(93)92123-B","article-title":"Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis","volume":"342","author":"Ogren","year":"1993","journal-title":"Lancet"},{"issue":"9","key":"10.1378\/chest.11-2307_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.CIR.0000120708.59903.1B","article-title":"Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study","volume":"109","author":"van der Meer","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1378\/chest.11-2307_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"issue":"9678","key":"10.1378\/chest.11-2307_bib11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"9759","key":"10.1378\/chest.11-2307_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1378\/chest.11-2307_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjmed.2011.01.018","article-title":"Effect of aspirin mortality in primary prevention of cardiovascular disease","volume":"124","author":"Raju","year":"2011","journal-title":"Am J Med"},{"key":"10.1378\/chest.11-2307_bib14","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"issue":"348","key":"10.1378\/chest.11-2307_bib15","first-page":"1329","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1378\/chest.11-2307_bib16","first-page":"CD001246","article-title":"Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","author":"Sudlow","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1378\/chest.11-2307_bib17","first-page":"CD005158","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease","author":"Keller","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1378\/chest.11-2307_bib18","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.11-2307_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","article-title":"Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study","volume":"35","author":"Johnson","year":"2002","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1378\/chest.11-2307_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure","volume":"28","author":"Sarac","year":"1998","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1378\/chest.11-2307_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","author":"Anand","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1378\/chest.11-2307_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archinte.159.4.337","article-title":"Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis","volume":"159","author":"Girolami","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1378\/chest.11-2307_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.0954-6820.1987.tb00891.x","article-title":"Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality","volume":"221","author":"Jonason","year":"1987","journal-title":"Acta Med Scand"},{"issue":"12","key":"10.1378\/chest.11-2307_bib24","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jama.1995.03530120067043","article-title":"Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis","volume":"274","author":"Gardner","year":"1995","journal-title":"JAMA"},{"issue":"9165","key":"10.1378\/chest.11-2307_bib25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(99)01163-0","article-title":"From effect size into number needed to treat","volume":"353","author":"Furukawa","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.11-2307_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jrsm.46","article-title":"Pooling health-related quality of life outcomes in meta-analysis\u2014a tutorial and review of methods for enhancing interpretability","author":"Thorlund","year":"2011","journal-title":"Research Synthesis Methods"},{"issue":"3","key":"10.1378\/chest.11-2307_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4244\/V5I3A60","article-title":"Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials","volume":"5","author":"Tamhane","year":"2009","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1378\/chest.11-2307_bib28","first-page":"CD003748","article-title":"Cilostazol for peripheral arterial disease","author":"Robless","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.11-2307_bib29","series-title":"Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline, and Inositol Nicotinate for Intermittent Claudication in People With Peripheral Arterial Disease","first-page":"1","author":"Squires","year":"2011"},{"issue":"2","key":"10.1378\/chest.11-2307_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jvs.2007.10.009","article-title":"Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects)","volume":"47","author":"Hiatt","year":"2008","journal-title":"J Vasc Surg"},{"issue":"17","key":"10.1378\/chest.11-2307_bib31","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1378\/chest.11-2307_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0741-5214(98)70357-X","article-title":"Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease","volume":"27","author":"Money","year":"1998","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1378\/chest.11-2307_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/153857440203600202","article-title":"Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study","volume":"36","author":"Strandness","year":"2002","journal-title":"Vasc Endovascular Surg"},{"issue":"5","key":"10.1378\/chest.11-2307_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvs.2008.11.098","article-title":"The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease","volume":"49","author":"O'Donnell","year":"2009","journal-title":"J Vasc Surg"},{"issue":"7","key":"10.1378\/chest.11-2307_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"issue":"12A","key":"10.1378\/chest.11-2307_bib36","doi-asserted-by":"crossref","first-page":"28D","DOI":"10.1016\/S0002-9149(01)01719-2","article-title":"Analysis of the cilostazol safety database","volume":"87","author":"Pratt","year":"2001","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1378\/chest.11-2307_bib37","first-page":"CD001999","article-title":"Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication","author":"Cosmi","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1378\/chest.11-2307_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9343(99)00224-7","article-title":"Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication","volume":"107","author":"Antonicelli","year":"1999","journal-title":"Am J Med"},{"issue":"2","key":"10.1378\/chest.11-2307_bib39","first-page":"73","article-title":"Efficacy and safety of a new low molecular weight heparin in the medium term treatment of atherosclerotic arteriopathy of the lower limbs","volume":"2","author":"Tesi","year":"1989","journal-title":"J Drug Dev"},{"issue":"3","key":"10.1378\/chest.11-2307_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/000331979304400304","article-title":"Clinical assessment of low molecular weight heparin effects in peripheral vascular disease","volume":"44","author":"Calabr\u00f2","year":"1993","journal-title":"Angiology"},{"issue":"1","key":"10.1378\/chest.11-2307_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000331979104200101","article-title":"Efficacy of low-molecular-weight heparin in the management of intermittent claudication","volume":"42","author":"Mannarino","year":"1991","journal-title":"Angiology"},{"issue":"3 suppl","key":"10.1378\/chest.11-2307_bib42","first-page":"41","article-title":"A new low molecular weight heparin in the treatment of peripheral arterial disease","volume":"7","author":"Palmieri","year":"1988","journal-title":"Int Angiol"},{"issue":"4","key":"10.1378\/chest.11-2307_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","article-title":"Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies","volume":"38","author":"Momsen","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1378\/chest.11-2307_bib44","first-page":"CD006544","article-title":"Prostanoids for critical limb ischaemia","author":"Ruffolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1378\/chest.11-2307_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.tvir.2009.08.005","article-title":"Acute limb ischemia","volume":"12","author":"Walker","year":"2009","journal-title":"Tech Vasc Interv Radiol"},{"issue":"suppl S","key":"10.1378\/chest.11-2307_bib46","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1378\/chest.11-2307_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semvascsurg.2008.12.004","article-title":"Proper evaluation and management of acute embolic versus thrombotic limb ischemia","volume":"22","author":"O'Connell","year":"2009","journal-title":"Semin Vasc Surg"},{"issue":"3","key":"10.1378\/chest.11-2307_bib48","first-page":"CD002784","article-title":"Surgery versus thrombolysis for acute limb ischaemia: initial management","author":"Berridge","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1378\/chest.11-2307_bib49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199804163381603","article-title":"A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs","volume":"338","author":"Ouriel","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1378\/chest.11-2307_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0950-821X(05)80239-7","article-title":"Surgical treatment versus thrombolysis in acute arterial occlusion: a randomised controlled study","volume":"6","author":"Nilsson","year":"1992","journal-title":"Eur J Vasc Surg"},{"issue":"6","key":"10.1378\/chest.11-2307_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0741-5214(94)70214-4","article-title":"A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia","volume":"19","author":"Ouriel","year":"1994","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1378\/chest.11-2307_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0741-5214(05)80036-9","article-title":"Thrombolysis or peripheral arterial surgery: phase I results","volume":"23","author":"Ouriel","year":"1996","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1378\/chest.11-2307_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0741-5214(96)70067-8","article-title":"Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity","volume":"24","author":"Weaver","year":"1996","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1378\/chest.11-2307_bib54","first-page":"CD001099","article-title":"Fibrinolytic agents for peripheral arterial occlusion","author":"Robertson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1378\/chest.11-2307_bib55","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/bjs.1800780831","article-title":"Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis","volume":"78","author":"Berridge","year":"1991","journal-title":"Br J Surg"},{"issue":"6","key":"10.1378\/chest.11-2307_bib56","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/152660280100800618","article-title":"Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial","volume":"8","author":"Mahler","year":"2001","journal-title":"J Endovasc Ther"},{"issue":"1","key":"10.1378\/chest.11-2307_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1148\/radiology.175.1.2107563","article-title":"Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial","volume":"175","author":"Meyerovitz","year":"1990","journal-title":"Radiology"},{"issue":"2","key":"10.1378\/chest.11-2307_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0720-048X(96)00742-5","article-title":"Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions","volume":"22","author":"Schweizer","year":"1996","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1378\/chest.11-2307_bib59","first-page":"CD002071","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","author":"D\u00f6rffler-Melly","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1378\/chest.11-2307_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/000331979004100402","article-title":"Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA","volume":"41","author":"Heiss","year":"1990","journal-title":"Angiology"},{"issue":"1","key":"10.1378\/chest.11-2307_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0950-821X(05)80126-4","article-title":"Platelet inhibition with ASA\/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial","volume":"8","author":"Study Group on Pharmacological Treatment After TPA","year":"1994","journal-title":"Eur J Vasc Surg"},{"issue":"2","key":"10.1378\/chest.11-2307_bib62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1148\/radiology.193.2.7972781","article-title":"Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty","volume":"193","author":"Do","year":"1994","journal-title":"Radiology"},{"issue":"1","key":"10.1378\/chest.11-2307_bib63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.CIR.83.1.141","article-title":"Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results","volume":"83","author":"Pilger","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.11-2307_bib64","series-title":"Fortschritte in der Angiologie","first-page":"355","article-title":"Rezidivprophylaxe nach perkutaner transluminaler Angioplastie (PTA): antikoagulation versus ticlopidin","author":"Schneider","year":"1987"},{"issue":"10","key":"10.1378\/chest.11-2307_bib65","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/000331970105201002","article-title":"Potential use of a low-molecular-weight heparin to prevent restenosis in patients with extensive wall damage following peripheral angioplasty","volume":"52","author":"Schweizer","year":"2001","journal-title":"Angiology"},{"issue":"1","key":"10.1378\/chest.11-2307_bib66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/eurheartj\/ehn514","article-title":"Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials","volume":"30","author":"Kasapis","year":"2009","journal-title":"Eur Heart J"},{"issue":"9201","key":"10.1378\/chest.11-2307_bib67","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial","volume":"355","author":"Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1378\/chest.11-2307_bib68","first-page":"CD000535","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","author":"Brown","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1378\/chest.11-2307_bib69","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/bjs.1800740406","article-title":"Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts","volume":"74","author":"Clyne","year":"1987","journal-title":"Br J Surg"},{"issue":"4","key":"10.1378\/chest.11-2307_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/153857448401800404","article-title":"A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts","volume":"18","author":"Goldman","year":"1984","journal-title":"Vasc Surg"},{"issue":"4","key":"10.1378\/chest.11-2307_bib71","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/153857448501900405","article-title":"The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts","volume":"19","author":"Donaldson","year":"1985","journal-title":"Vasc Surg"},{"issue":"6","key":"10.1378\/chest.11-2307_bib72","first-page":"1016","article-title":"Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency","volume":"92","author":"Green","year":"1982","journal-title":"Surgery"},{"issue":"3","key":"10.1378\/chest.11-2307_bib73","first-page":"462","article-title":"Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts","volume":"96","author":"Kohler","year":"1984","journal-title":"Surgery"},{"issue":"1","key":"10.1378\/chest.11-2307_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0741-5214(91)90022-M","article-title":"Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial","volume":"13","author":"McCollum","year":"1991","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1378\/chest.11-2307_bib75","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1378\/chest.11-2307_bib76","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1161\/STROKEAHA.110.581058","article-title":"Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis","volume":"41","author":"de Weerd","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1378\/chest.11-2307_bib77","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Lansberg","year":"2012","journal-title":"Chest"},{"issue":"2 suppl","key":"10.1378\/chest.11-2307_bib78","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.11-2307_bib79","first-page":"CD001458","article-title":"Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy","author":"Engelter","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1378\/chest.11-2307_bib80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.STR.9.4.309","article-title":"Controlled trial of aspirin in cerebral ischemia. Part II: surgical group","volume":"9","author":"Fields","year":"1978","journal-title":"Stroke"},{"issue":"10","key":"10.1378\/chest.11-2307_bib81","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.STR.19.10.1211","article-title":"Danish very-low-dose aspirin after carotid endarterectomy trial","volume":"19","author":"Boysen","year":"1988","journal-title":"Stroke"},{"issue":"3","key":"10.1378\/chest.11-2307_bib82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00000658-199003000-00002","article-title":"Antiplatelet treatment prolongs survival after carotid bifurcation endarterectomy. Analysis of the clinical series followed by a controlled trial","volume":"211","author":"Kretschmer","year":"1990","journal-title":"Ann Surg"},{"issue":"8","key":"10.1378\/chest.11-2307_bib83","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.STR.24.8.1125","article-title":"Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial","volume":"24","author":"Lindblad","year":"1993","journal-title":"Stroke"},{"issue":"9","key":"10.1378\/chest.11-2307_bib84","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-116-9-731","article-title":"Failure of aspirin plus dipyridamole to prevent restenosis after carotid endarterectomy","volume":"116","author":"Harker","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1378\/chest.11-2307_bib85","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/030006059101900305","article-title":"Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study","volume":"19","author":"Pratesi","year":"1991","journal-title":"J Int Med Res"},{"issue":"9171","key":"10.1378\/chest.11-2307_bib86","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212601354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212601354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:34:39Z","timestamp":1757918079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212601354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0012369212601354"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-2307","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy in Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-2307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}